MedCity News
FEBRUARY 12, 2025
The consequences for not prioritizing new guidelines for CKD screening have a devastating impact on population health by increasing the global mortality rate and driving higher healthcare costs. The post Prioritizing CKD Screening Guidelines is Imperative to Combat Global Health Crisis appeared first on MedCity News.
PharmaVoice
FEBRUARY 12, 2025
As drug development priorities shift, pharma companies need to understand younger patients to improve their reputation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
FEBRUARY 12, 2025
Integrating nursing expertise into technology design, development, and implementation fosters early user support, establishes credibility with the technology, and leads to significantly better usage across the organization, avoiding the creation of process workarounds. The post The Nurse as Designer: Breaking Down Barriers with Clinician-Center Innovation appeared first on MedCity News.
European Pharmaceutical Review
FEBRUARY 12, 2025
The European Commission has approved acoramidis as the first near complete TTR stabiliser (90 percent) to treat transthyretin amyloidosis in adults with cardiomyopathy (ATTR-CM) patients in the US and EU. BEYONTTRA (acoramidis) is indicated for adults with wild-type or variant ATTR-CM. This disease is progressively fatal and results in heart failure, BridgeBio Pharma, Inc. explained.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
FEBRUARY 12, 2025
SpringWorks Therapeutics Gomekli is now FDA approved for treating tumors caused by the rare genetic disorder neurofibromatosis type 1. The approval comes as SpringWorks has emerged as a potential acquisition target. The post FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
FEBRUARY 12, 2025
The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! The post Who is Speaking at INVEST 2025? appeared first on MedCity News.
pharmaphorum
FEBRUARY 12, 2025
Merck KGaA is talking to SpringWorks about a takeover, and FDA approval for a neurofibromatosis drug could have sweetened any potential deal.
MedCity News
FEBRUARY 12, 2025
Centivo and Premise Health are launching a new primary care-focused health plan that will become available to employers in the 2026 benefits cycle. The post Centivo, Premise Health Strike Partnership to Create Primary Care-Focused Health Plan appeared first on MedCity News.
PharmaTimes
FEBRUARY 12, 2025
UCB's BIMZELX reveals promising two-year data at EHSF 2025
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
FEBRUARY 12, 2025
Abcuro has raised $200m in financing that should allow it to complete a pivotal trial of ulviprubart for rare disease inclusion body myositis (IBM).
PharmaTech
FEBRUARY 12, 2025
Pharmaceutical Technology sat down with Jean Redmond, Chief Operating Officer at Biologit, to discuss the use of artificial intelligence in pharmaceutical research and development and the role women play in this fast-developing area.
pharmaphorum
FEBRUARY 12, 2025
BridgeBio and Bayer are poised to challenge Pfizer's Vyndaqel in the EU after acoramidis gets a green light for ATTR cardiomyopathy.
PharmaTimes
FEBRUARY 12, 2025
Potential treatment for multiple system atrophy shows promise
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Technology
FEBRUARY 12, 2025
GlobalDatas Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
pharmaphorum
FEBRUARY 12, 2025
An e-Book aimed at children with rare kidney disease aHUS can help them understand the condition, deal with emotions, and find support, says Alexion.
Pharmaceutical Technology
FEBRUARY 12, 2025
Traveres stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.
Pharmaceutical Commerce
FEBRUARY 12, 2025
The facilities are expected to offer pharma shipment support by addressing time and temperature-specific requirements.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
FEBRUARY 12, 2025
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Pharmaceutical Commerce
FEBRUARY 12, 2025
In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, dives into specific areas where FDA investment could have the greatest impact in accelerating approval timelines.
Pharmaceutical Technology
FEBRUARY 12, 2025
Lundbeck has received the US FDA fast track designation for amlenetug, a potential treatment for multiple system atrophy (MSA).
PharmaTech
FEBRUARY 12, 2025
Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Technology
FEBRUARY 12, 2025
EC has granted marketing authorisation to BridgeBio Pharmas acoramidis under the Beyonttra brand name for treating ATTR-CM.
PharmaTech
FEBRUARY 12, 2025
Acoramidis was approved by FDA in November 2024 and is prescribed in the US under the brand name Attruby.
Pharmaceutical Technology
FEBRUARY 12, 2025
Health Canada has approved MSD's Keytruda for treating adults with resectable stage II, IIIA or IIIB NSCLC.
PharmExec
FEBRUARY 12, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Commerce
FEBRUARY 12, 2025
Digging a little deeper into the drug class phenomenon reveals some interesting takeaways on a smaller subgroup of users.
PharmExec
FEBRUARY 12, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
FEBRUARY 12, 2025
Our February issue is highlighted by an examination of the latest trends and strategies from the perspective of third-party logistics providers, and introduces new expert commentary covering a pair of pivotal realms in the pharma supply chain journey.
Expert insights. Personalized for you.
242 
Let's personalize your content